Review on the Current Limitations to the Treatment of Ischemic Heart Disease Through Cardiovascular Tissue Engineering Applications
The Future of Ischemic Heart Disease Treatment
DOI:
https://doi.org/10.58445/rars.431Keywords:
Ischemic Heart Disease, Vascular Graft, Bioprinting, Extracellular MatrixAbstract
Ischemic heart disease is the most prevalent cardiovascular disease in the world. Current treatments primarily rely on organ transplantations; however, issues including lifelong medication to prevent immune rejection, trauma to the cardiovascular system, and the lack of organ donations are yet to be addressed. With the development of current cardiovascular tissue engineering technologies, namely artificial valves, vascular grafts, synthetic scaffolds, and computational approaches, this field has the potential to provide alternative treatment options for ischemic heart disease. This review article aims to cover the effects of ischemic heart disease on the heart and the circulatory system and explore the process, benefits, and limitations of the current approaches to the treatment of ischemic heart disease.
References
. World Health Organization. “Cardiovascular Diseases.” World Health Organization, World Health Organization, 11 June 2021, www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
. Heart Disease and Stroke Prevention. www.health.ny.gov/diseases/cardiovascular/heart_disease.
. Davis, Charles Patrick. “How the Heart Works: Get Facts about the Human Heart.” MedicineNet, 15 Apr. 2020, www.medicinenet.com/heart_how_the_heart_works/article.htm.
. “Ischemic Heart Disease | Advocate Health Care.” Www.advocatehealth.com, www.advocatehealth.com/health-services/advocate-heart-institute/conditions/ischemic-heart-disease.
. Eskerud, Ingeborg, et al. “Left Ventricular Hypertrophy Contributes to Myocardial Ischemia in Non-Obstructive Coronary Artery Disease (the MicroCAD Study).” International Journal of Cardiology, vol. 286, July 2019, pp. 1–6, https://doi.org/10.1016/j.ijcard.2019.03.059. Accessed 3 Nov. 2021.
. Cleveland Clinic. “Blood Vessels: Types, Anatomy, Function & Conditions.” Cleveland Clinic, 7 Sept. 2021, my.clevelandclinic.org/health/body/21640-blood-vessels.
. Severino, Paolo, et al. “Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.” International Journal of Molecular Sciences, vol. 21, no. 9, 30 Apr. 2020, p. 3167, https://doi.org/10.3390/ijms21093167.
. Liu, Nanbo, et al. “Advances in 3D Bioprinting Technology for Cardiac Tissue Engineering and Regeneration.” Bioactive Materials, vol. 6, no. 5, Nov. 2020, pp. 1388–401, https://doi.org/10.1016/j.bioactmat.2020.10.021. Accessed 14 June 2021.
. Seifu, Dawit G., et al. “Small-Diameter Vascular Tissue Engineering.” Nature Reviews Cardiology, vol. 10, no. 7, May 2013, pp. 410–21, https://doi.org/10.1038/nrcardio.2013.77. Accessed 27 June 2021.
. Syedain, Zeeshan, et al. “6-Month Aortic Valve Implantation of an Off-The-Shelf Tissue-Engineered Valve in Sheep.” Biomaterials, vol. 73, Dec. 2015, pp. 175–184, https://doi.org/10.1016/j.biomaterials.2015.09.016. Accessed 11 Dec. 2019.
. Pashneh-Tala, Samand, et al. “The Tissue-Engineered Vascular Graft—Past, Present, and Future.” Tissue Engineering Part B: Reviews, vol. 22, no. 1, Feb. 2016, pp. 68–100, https://doi.org/10.1089/ten.teb.2015.0100.
. Shakeel, Adeeba, and Peter R. Corridon. “Mitigating Challenges and Expanding the Future of Vascular Tissue Engineering—Are We There Yet?” Frontiers in Physiology, vol. 13, Jan. 2023, https://doi.org/10.3389/fphys.2022.1079421. Accessed 3 July 2023.
. Quadri, Faisal, et al. “Progress in Cardiovascular Bioprinting.” Artificial Organs, Feb. 2021, https://doi.org/10.1111/aor.13913. Accessed 18 May 2021.
Additional Files
Posted
Categories
License
Copyright (c) 2023 Nicolas Xu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.